Lahti, Adrienne

Lahti, Adrienne
Professor

Professor (P), Psychiatry - Behavioral Neurobiology , Psychiatry 2006 -
Scientist (C), Civitan International Research Center , Academic Joint Departments 2006 -
Scientist (C), Center for Dev Func Imaging (CDFI) (Retired Org) , Vision Sciences (Retired Org) 2007 -
Scientist (C), Comprehensive Neuroscience Center , General Clinical Research Center 2008 -
Scientist (C), Center for Clinical and Translational Science (CCTS) , General Clinical Research Center 2009 -
Professor (S), Psychology , College of Arts and Sciences 2013 -
Senior Scientist (C), Vision Science Research Center (Retired Org) , Vision Sciences (Retired Org) 2013 -
Investigator (C), Evelyn F. McKnight Brain Institute , Neurology 2017 -
Vice Chairperson, Psychiatry - Behavioral Neurobiology , Psychiatry 2017 -

Selected Publications

Academic Article

Year	Title	Altmetric
2019	A longitudinal magnetic resonance spectroscopy study investigating effects of risperidone in the anterior cingulate cortex and hippocampus in schizophrenia. Schizophrenia Research. 210:239-244. 2019
2019	Cognitive control network dysconnectivity and response to antipsychotic treatment in schizophrenia. Schizophrenia Research. 204:262-270. 2019
2019	7T Proton Magnetic Resonance Spectroscopy of the Anterior Cingulate Cortex in First-Episode Schizophrenia. Schizophrenia Bulletin. 45:180-189. 2019
2019	Examining resting-state functional connectivity in first-episode schizophrenia with 7T fMRI and MEG. NeuroImage: Clinical. 24. 2019
2018	Evaluation of fronto-striatal networks during cognitive control in unmedicated patients with schizophrenia and the effect of antipsychotic medication. npj Schizophrenia. 4. 2018
2018	Neurometabolic abnormalities in the associative striatum in antipsychotic-naïve first episode psychosis patients. Psychiatry Research: Neuroimaging. 281:101-106. 2018
2018	Four-way multimodal fusion of 7 T imaging data using an mCCA+jICA model in first-episode schizophrenia. Human Brain Mapping. 39:1475-1488. 2018
2018	Mnemonic Discrimination Deficits in First-Episode Psychosis and a Ketamine Model Suggests Dentate Gyrus Pathology Linked to N-Methyl-D-Aspartate Receptor Hypofunction. Biological Psychiatry: Cognitive Neuroscience and Neuroimaging. 3:231-238. 2018
2018	Paving the way for targeted drug development in schizophrenia. JAMA Psychiatry. 75:19-20. 2018
2017	Brain structure, function, and neurochemistry in schizophrenia and bipolar disorder- A systematic review of the magnetic resonance neuroimaging literature. npj Schizophrenia. 3. 2017
2017	Glutamate/glutamine concentrations in the dorsal anterior cingulate vary with Post-Traumatic Stress Disorder symptoms. Journal of Psychiatric Research. 91:169-176. 2017
2017	Ketamine modulates hippocampal neurochemistry and functional connectivity: A combined magnetic resonance spectroscopy and resting-state fMRI study in healthy volunteers. Molecular Psychiatry. 22:562-569. 2017
2017	The effect of saccadic eye movements on the sensor-level magnetoencephalogram. Electromyography and Clinical Neurophysiology. 128:397-407. 2017
2017	Risperidone effects on brain dynamic connectivity-A prospective resting-state fMRI study in Schizophrenia. Frontiers in Psychiatry. 8. 2017
2017	Predictors of medication adherence and smoking cessation among smokers under community corrections supervision. Addictive Behaviors. 65:111-117. 2017
2016	A combined diffusion tensor imaging and magnetic resonance spectroscopy study of patients with schizophrenia. Schizophrenia Research. 170:341-350. 2016
2016	Aberrant hippocampal connectivity in unmedicated patients with schizophrenia and effects of antipsychotic medication: A longitudinal resting state functional mri study. Schizophrenia Bulletin. 42:1046-1055. 2016
2015	Effective connectivity during episodic memory retrieval in schizophrenia participants before and after antipsychotic medication. Human Brain Mapping. 36:1442-1457. 2015
2014	Ventral tegmental area/midbrain functional connectivity and response to antipsychotic medication in schizophrenia. Neuropsychopharmacology. 39:1020-1030. 2014
2014	Delay discounting and task performance consistency in patients with schizophrenia. Psychiatry Research. 215:286-293. 2014
2014	Basal ganglia volume in unmedicated patients with schizophrenia is associated with treatment response to antipsychotic medication. Psychiatry Research: Neuroimaging. 221:6-12. 2014
2014	A Full-Brain, Bootstrapped Analysis of Diffusion Tensor Imaging Robustly Differentiates Parkinson Disease from Healthy Controls. Neuroinformatics. 13:7-18. 2014
2014	Expectancies for the effectiveness of different tobacco interventions account for racial and gender differences in motivation to quit and abstinence self-efficacy. Nicotine and Tobacco Research. 16. 2014
2014	Hippocampal-parietal dysconnectivity and glutamate abnormalities in unmedicated patients with schizophrenia. Hippocampus. 24:1524-1532. 2014
2014	How low should you go? Determining the optimal cutoff for exhaled carbon monoxide to confirm smoking abstinence when using cotinine as reference. Nicotine and Tobacco Research. 16:1348-1355. 2014
2014	Open label smoking cessation with varenicline is associated with decreased glutamate levels and functional changes in anterior cingulate cortex: Preliminary findings. Frontiers in Pharmacology. 5 JUL. 2014
2014	Synaptic proteins in the postmortem anterior cingulate cortex in schizophrenia: Relationship to treatment and treatment response. Neuropsychopharmacology. 39:2095-2103. 2014
2014	Vergence eye movements in patients with schizophrenia. Vision Research. 102:64-70. 2014
2013	Increased hippocampal glutamate and volumetric deficits in unmedicated patients with schizophrenia. JAMA Psychiatry. 70:1294-1302. 2013
2011	Aberrant visual circuitry associated with normal spatial match-to-sample accuracy in schizophrenia. Psychiatry Research: Neuroimaging. 193:138-143. 2011
2011	Is there evidence for neurotoxicity in the prodromal and early stages of schizophrenia. Neuropsychopharmacology. 36:1779-1780. 2011
2011	Mitochondria in the striatum of subjects with schizophrenia: Relationship to treatment response. Synapse. 65:215-224. 2011
2010	Assessments of function and biochemistry of the anterior cingulate cortex in schizophrenia. Biological Psychiatry. 68:625-633. 2010
2010	Gamma and delta neural oscillations and association with clinical symptoms under subanesthetic ketamine. Neuropsychopharmacology. 35:632-640. 2010
2009	Modulation of limbic circuitry predicts treatment response to antipsychotic medication: A functional imaging study in schizophrenia. Neuropsychopharmacology. 34:2675-2690. 2009
2009	Dopaminergic synapses in the caudate of subjects with schizophrenia: Relationship to treatment response. Synapse. 63:520-530. 2009
2006	Correlations between rCBF and symptoms in two independent cohorts of drug-free patients with schizophrenia. Neuropsychopharmacology. 31:221-230. 2006
2005	Effects of noncompetitive NMDA receptor blockade on anterior cingulate cerebral blood flow in volunteers with schizophrenia. Neuropsychopharmacology. 30:2275-2282. 2005
2005	The effects of a subanesthetic dose of ketamine on verbal memory in normal volunteers. Psychopharmacology. 183:265-274. 2005
2005	Functional effects of single dose first- and second-generation antipsychotic administration in subjects with schizophrenia. Psychiatry Research: Neuroimaging. 139:19-30. 2005
2004	Parametric study of accuracy and response time in schizophrenic persons making visual or auditory discriminations. Psychiatry Research. 127:207-216. 2004
2000	Ketamine effects on eye movements. Neuropsychopharmacology. 23:645-653. 2000
2000	The limbic cortex in schizophrenia: Focus on the anterior cingulate. Brain Research Reviews. 31:364-370. 2000
2000	Brain activation patterns in schizophrenic and comparison volunteers during a matched-performance auditory recognition task. American Journal of Psychiatry. 157:1634-1645. 2000
2000	Decisional capacity for informed consent in schizophrenia research. Archives of General Psychiatry. 57:533-538. 2000
1998	Effects of the D3 and autoreceptor-preferring dopamine antagonist (+)-UH232 in schizophrenia. Journal of Neural Transmission. 105:719-734. 1998
1998	Cerebral blood flow relationships associated with a difficult tone recognition task in trained normal volunteers. Cerebral Cortex. 8:534-542. 1998
1998	The relationship between smooth pursuit eye movements and tardive dyskinesia in schizophrenia. Schizophrenia Research. 31:141-150. 1998
1998	Antipsychotic properties of the partial dopamine agonist (-)-3-(3- hydroxyphenyl)-N-n-propylpiperidine (preclamol) in schizophrenia. Biological Psychiatry. 43:2-11. 1998
1998	Association between eye tracking disorder in schizophrenia and poor sensory integration. American Journal of Psychiatry. 155:1352-1357. 1998
1997	Eye tracking disorder in schizophrenia is characterized by specific ocular motor defects and is associated with the deficit syndrome. Biological Psychiatry. 42:781-796. 1997